|

D2C7-IT Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 2Phase 1/2: 1

Top Sponsors

  • Darell Bigner3

Indications

  • Cancer3
  • Newly Diagnosed MGMT Unmethylated Glioblastoma1
  • Recurrent Glioblastoma, IDH-Wildtype1
  • Glioma, Malignant1

Durham, North Carolina3 trials

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Duke University Medical Center

Phase 1
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Duke University Medical Center

Phase 1/2
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Duke University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.